InvestorsHub Logo
Followers 655
Posts 19369
Boards Moderated 6
Alias Born 07/03/2011

Re: Pedro2004 post# 73

Wednesday, 12/07/2022 5:10:11 AM

Wednesday, December 07, 2022 5:10:11 AM

Post# of 4264
TransCode Therapeutics Announces Withdrawal of Registration Statement
December 06 2022 - 04:20PM
GlobeNewswire Inc.
Alert
Print
Share On Facebook

TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (the “Company”), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, announced today that it withdrew the Registration Statement on Form S-1 it filed with the U.S. Securities and Exchange Commission on November 28, 2022, and amended on November 30, 2022. The withdrawal reflects the Company’s belief that current market conditions are not conducive for an offering on terms that would be in the best interests of the Company's stockholders.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy the Company’s common stock or any securities, and there shall not be any offer, solicitation or sale of securities mentioned in the press release in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such any state or jurisdiction.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RNAZ News